Pentadecapeptide BPC 157 interactions with adrenergic and dopaminergic systems in mucosal protection in stress

Digestive Diseases and Sciences

Volumn 42, Issue 3, 1997, Pages 661-671

  Sikirić, Predrag ^a   Mazul, Branka ^a   Seiwerth, Sven ^a   Grabarević, Željko ^a   Ručman, Rudolf ^a   Petek, Marijan ^a   Jagić, Vjekoslav ^a   Turković, Branko ^a   Rotkvić, Ivo ^a   Miše, Stjepan ^a   Zoričić, Ivan ^a   Jurina, Ljubica ^a   Konjevoda, Paško ^a   Hanževački, Miroslav ^a   Gjurašin, Miroslav ^a   Šeparović, Jadranka ^a   Ljubanović, Danica ^a   Artuković, Branka ^a   Bratulić, Mirna ^a   Tišljar, Marina ^a   Miklić, Pavao ^a   Sumajstorčić, Jagoda ^a   more..

^a UNIVERSITY OF ZAGREB   (Croatia)

Author keywords

adrenergic dopaminergic systems; gastroprotection; interaction; pentadecapeptide BPC 157; peptide BPC; stress

Indexed keywords

ADRENALIN; ATENOLOL; BROMOCRIPTINE; CLONIDINE; DOMPERIDONE; GLYCYLGLUTAMYLPROLYLPROLYLPROLYLGLYCYLLYSYLPROLYLALANYLASPARTYLASPARTYLALANYLGLYCYLLEUCYLVALINE; HALOPERIDOL; PENTAPEPTIDE; PHENTOLAMINE; PRAZOSIN; PROPRANOLOL; UNCLASSIFIED DRUG; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG MECHANISM; INTRAGASTRIC DRUG ADMINISTRATION; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; NONHUMAN; PEPTIC ULCER; PRIORITY JOURNAL; RAT; STOMACH PROTECTION; STRESS;

ADRENERGIC AGENTS; ANIMALS; ANTI-ULCER AGENTS; DISEASE MODELS, ANIMAL; DOPAMINE AGENTS; DRUG EVALUATION, PRECLINICAL; DRUG INTERACTIONS; GASTRIC MUCOSA; MALE; PEPTIDE FRAGMENTS; PROTEINS; RANDOM ALLOCATION; RATS; RATS, WISTAR; RECEPTORS, ADRENERGIC; RECEPTORS, DOPAMINE; STOMACH ULCER; STRESS, PSYCHOLOGICAL;

EID: 8244245261     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1018880000644     Document Type: Article

References (63)

1. Guglietta A: Possible clinical use of peptide growth factors in the GI tract: Perspectives and obstacles. Exp Clin Gastroenterol 3:1-6, 1993
2. Thompson JC, Greeley GH, Rayford PL, Townsend CM: Gastrointestinal Endocrinology. New York, McGraw-Hill, 1987
3. Sikiric P, Petek M, Rucman R, Seiwerth S, Grabarevic Z, Rotkvic I, Jagic V, Mildner B, Duvnjak M, Lang N: A new gastric juice peptide, BPC - an overview of stomach/stress/organoprotection hypothesis and BPC beneficial effects. J Physiol (Paris) 87:313-327, 1993
4. 4 administration. A comparative study with dopamine agonists and somatostatin. Life Sci, 53:PL 291-PL 296, 1993
5. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Rotkvic I, Turkovic B, Udovicic I, Jagic V, Mildner B, Duvnjak M, Danilovic Z: The effect of pentadecapeptide BPC 157 on inflammatory, non-inflammatory, direct and indirect pain and capsaicin neurotoxicity. Inflammopharmacology 2:121-127, 1993
6. 2 receptor antagonists, dopamine promotors and gut peptides. Life Sci 54:PL63-PL68, 1994
7. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Gjurasin M, Konjevoda P, Separovic J, Ljubanovic D, Artukovic B, Bratulic M, Tisljar M, Jurina Lj, Buljat G, Miklic P, Marovic A: The beneficial effect of a novel pentadecapeptide BPC 157 on gastric lesions induced by restraint stress, ethanol, indomethacin and capsaicin neurotoxicity. Dig Dis Sci 41:1604-1614, 1996
8. Sikiric P, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Jurina LJ, Konjevoda P, Hanzevacki M, Ljubanovic D, Separovic J, Gjurasin M, Bratulic M, Artukovic B, Jelovac N, Buljat G: Salutary and prophylactic effect of pentadecapeptide BPC 157 on acute pancreatitis and concomitant gastroduodenal lesions in rats. Dig Dis Sci 41:1518-1526, 1996
9. Sikiric P, Mikus D, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Peric J, Konjevoda P, Perovic D, Jurina LJ, Hanzevacki M, Separovic J, Gjurasin M, Jadrijevic S, Jelovac N, Miklic P, Buljat G, Marovic A: Pentadecapeptide BPC 157, cimetidine, ranitidine, bromocriptine, and atropine effect in cysteamine lesions in totally gastrectomized rats. A model for cytoprotective studies. Dig Dis Sci 1997 (in press)
10. Sikiric P, Mikus D, Seiwerth S, Grabarevic Z, Rucman R, Petek M, Jagic V, Turkovic B, Rotkvic I, Mise S, Zoricic I, Konjevoda P, Perovic D, Simicevic V, Separovic J, Hanzevacki M, Ljubanovic D, Artukovic B, Bratulic M, Tisljar M, Rekic B, Gurasin M, Miklic P, Buljat G: Pentadecapeptide BPC 157 positively affects both non-steroidal anti-inflammatory agents-induced gastrointestinal lesions and adjuvant arthritis in rats. J Physiol (Paris), 1997 (in press)
11. Grabarevic Z, Tisljar M, Artukovic B, Bratulic M, Dzaja P, Seiwerth S, Sikiric P, Peric J, Geres D, Kos J: The influence of BPC 157 on nitric-oxyde agonists and antagonist induced lesions in broiler chicks. J Physiol (Paris), 1997 (in press)
12. Paré W, Klucyznski JM: The effect of new gastric juice peptide BPC on classic stress triad in stress procedure. Exp Clin Gastroenterol 2:234-236, 1992
13. Veljaca M, Pllana R, Lesch CA, Sanchez B, Chan K, Guglietta A: Protective effect of BPC 157 on a rat model of colitis. Gastroenterology 106:789, 1994
14. Veljaca M, Lech CA, Pllana R, Sanchez B, Chan K, Guglietta A: BPC-15 reduces trinitrobenzene sulfonic acid-induced colonic damage in rats. J Pharmacol Exp Ther 272:417-422, 1994
15. Veljaca M, Lesch CA, Sanchez B, Low J, Guglietta A: Protection of BPC-15 on TNBS-induced colitis in rats: Possible mechanisms of action. Gastroenterology 108:936, 1995
16. Bosnjak ZJ, Graf BM, Sikiric P, Stowe DF: Protective effects of newly isolated gastric peptide following hypoxic and reoxygenation injury in the isolated guinea pig heart. FASEB J 8:A129, 1994
17. Sandor Z., Vincze A, Szabo S: The protective effect of a recently isolated gastric peptide in acute and chronic gastroduodenal injury. FASEB J 10:A171, 1996
18. Veljaca M, Chan K, Guglietta A: Digestion of h-EGF, h-TGF alfa, and BPC 15 in human gastric juice. Pharmacol Res 31:70, 1995
19. Brkic T, Banic M, Anic B, Grabarevic Z, Rotkvic I, Artukovic B, Duvnjak M, Sikiric, P, Troskot B, Hernandez DF: A model of inflammatory bowel disease induced by 2,4-dinitrophlourbenzene in previously sensitized BALB-c mice. Scand J Gastroenterol 27:184-188, 1992
20. Tache Y, Simard P, Collu R: Prevention by bombesin of coloid-restraint stress induced gastric ulcers in rats. Life Sci 24:1719-1726, 1979
21. Heiling M, Marison R: Intracerebroventricular neuropeptide Y protects against stress-induced gastric lesions in rat. Eur J Pharmacol 137:127-129, 1987
22. Szabo S, Usadel KH: Cytoprotection-organoprotection by somatostatin: Gastric and hepatic lesions. Experientia 38:254-256, 1982
23. Senecic I, Sikiric P, Giljanovic S: The effects of somatostatin on stress-induced gastric lesions in mice. Exp Clin Gastroenterol 1:171-173, 1991
24. Takeuchi K, Johnson LR: Pentagastrin protects against stress ulceration in rats. Gastroenterology 76:788-792, 1979
25. Evangelista S, Renzi D, Guzzi P, Maggi CA: Decrease of gastric calcitonin gene related peptide-like immunoreaetivity is associated with ulcers induced by water immersion stress in rats. Exp Clin Gastroenterol 1:51-53, 1991
26. Guth PH, Mecriff JC, Paulsen G: Prevention by glucagon of experimental stress induced hemorrhagic gastritis. Gastroenterology 69:1048-1050, 1975
27. Evangelista S, Maggi CA: Protection induced by cholecystokinin-8 (CCK-8) in ethanol-induced gastric lesions is mediated via vagal capsaicin-sensitive fibers and CCKA receptors. Br J Pharmacol 102:119-122, 1991
28. Sikiric P, Rotkvic I, Mise S, Seiwerth S, Grabarevic Z, Petek M, Rucman R, Zjacic-Rotkvic V, Duvnjak M, Jagic V, Suchanek E, Marovic A, Banic M, Brkic T, Hanzevacki M, Separovic J, Djacic S, Simicevic V: Dopamine agents efficacy in peptic ulcer healing and relapse prevention - a further indication for importance of stomach dopamine in the stress organoprotection concept. In Neuroendocrinology of Gastrointestinal Ulceration: Hans Selye Symposia on Neuroendocrinology and Stress, Volume 2. S Szabo, Y, Taché, G Glavin (eds). New York, Plenum Publishing, 1995, pp 221-231
29. Hernandez DH, Adcock JW, Orlando RC, Patrick KS, Nemeroff CB, Prange AJ: Prevention of stress-induced gastric ulcers by dopamine agonists in rat. Life Sci 35:2453-2458, 1983
30. Szabo S: Dopamine disorder in duodenal ulceration. Lancet 2:880-882, 1979
31. Sikiric P, Geber J, Suchanek H, Ivanovic D, Gjuris V, Aleksic J, Reic P, Marovic A: The role of dopamine in the formation of gastric ulcer in rats. Eur J Pharmacol 112:127-128, 1985
32. Sikiric P, Rotkvic I, Mise S, Seiwerth S, Grabarevic Z, Petek M, Rucman R: Dopamine, PGs and somatostatin in gastric protection in rats. Eur J Pharmacol 183:2026-2027, 1990
33. Sikiric P, Rotkvic I, Mise S, Krizanac S, Gjuris V, Jukic J, Suchanek E, Petek M, Udovicic I, Kalogjera L, Geber J, Tucan-Foretic M, Duvnjak M, Philipp M, Balen I, Anic T: The influence of dopamine agonists and antagonists on indomethacin lesions in stomach and small intestine in rats. Eur J Pharmacol 158:61-67, 1998
34. Sikiric P, Geber J, Ivanovic D, Suchanek E, Gjuris V, Tucan-Foretic M, Mise S, Cvitanovic B, Rotkvic I: Dopamine antagonists induce gastric lesions in rats. Eur J Pharmacol 131:105-109, 1986
35. Sikiric P, Rotkvic I, Mise S, Krizanac S, Suchanek E, Petek M, Gjuris V, Tucan-Foretic M, Udovicic I, Anic T, Balen I: The influence of dopamine agonists and antagonists on gastric lesions in mice. Eur J Pharmacol 144:237-239, 1987
36. Hernandez DE: Neuroendocrine mechanisms of stress ulceration: Focus on thyrotropin releasing hormone (TRH). Life Sci 39:279-296, 1986
37. Paré W, Glavin G: Restraint stress in biomedical research: A review. Neurosci Biobehav Rev 10:334-370, 1986
38. Glavin G, Paré W, Sandbak T, Bakke HK, Murison R: Restraint stress in biomedical research: An update. Neurosci Rev 18:223-249, 1994
39. 1 imidazoline receptor agonist, moxonidine, on gastric secretion and gastric mucosal injury in rats. Br J Pharmacol 114:751-754, 1995
40. Kent S, Hurd M, Satinoff E: Phentolamine and thermoregulation in rats. Pharmacol Biooch Behav 40:709-716, 1991
41. Ray A, Sullivan R, Henke P: Adrenergic modulation of gastric stress pathology in rats: A cholinergic link. J Autonom Nerv System 20:265-268, 1987
42. Lauva IK, Tomanek RJ: The effects of beta adrenoceptor blockade with atenolol on myocardial cellular and subcellular hypertrophy in spontaneously hypertensive rats. Anat Rec 207:615-622, 1983
43. Tsou MY, Lui PW, Lee TY, Pan JT, Chan SHH: Differential effects of prazosin and yohimbine on fentanyl-induced muscular rigidity in rats. Neuropharmacology 28:1163-1168, 1989
44. Sikiric P, Rolkvic I, Seiwerth S, Grabarevic Z, Mise S, Duvnjak M, Artukovic B, Dernikovic K, Dodig M, Djermanovic Z, Senecic I, Giljanovic S, Kalogjera L, Rogina Z, Djaja P, Uglesic M: The differences between dopamine gastric and spleen protection in restraint stress. Dig Dis Sci 35:1040, 1990
45. Sikiric P, Rotkvic I, Seiwerth S, Grabarevic Z, Duvnjak M, Jagic V, Artukovic B, Djermanovic Z, Dodig M, Senecic I, Giljanovic S, Erceg D, Komericki L, Banic M, Brkic T, Anic T: The differences between dopamine gastric and testis protection in restraint stress. Dig Dis Sci 35:1040, 1990
46. Robert A, Phillips P, Nezamis JE: Production by restraint of gastric ulcers and of hydrothorax in the rat. Gastroenterology 51:75-81, 1996
47. Robert A, Nezamis JE, Lancaster C, Badalamenti JN: Cysteamine-induced duodenal ulcers: A new model to test antulcer agents. Digestion 11:199-214, 1974
48. Abdel-Rehim M, Taha S, Abu-Sitta S, Taymour A, El Fiky M, Ibrahim I: A comparative study on the effects of atropine, cimetidine, sulpiride, chlorpromazine and propranolol on gastric stress ulcer. Egypt J Med Sci 7:11-18, 1986
49. Kuratani K, Yamazaki M, Kodama H, Yamaguchi I: Possible involvement of hyperinsulinemia and adrenergic activation in the pathogenesis of indomethacin-induced antral ulcers in nonfasted hamsters and refed rats. J Pharmacol Exp Ther 263:951-955, 1992
50. Kiro A, Zahavi I, Marcus H, Dinari G: L-dopa is protective against indomethacin-induced small intestinal ulceration in the rat: possible role of an alpha-2-adrenergic mechanism. Life Sci 51:1151-1156, 1992
51. Tepperman BL, Whittle BJ: Comparison of the effects of neuropeptide Y and noradrenaline on rat gastric mucosal blood flow and integrity. Br J Pharmacol 102:95-100, 1991
52. Nakane T, Kanie N, Audhya T, Hollander C: The effects of centrally administered neruopeptides on the development of gastric lesions in rats. Life Sci. 36:1197-1203, 1985
53. Haeusler G: Activation of the central pathway of the baroreceptor reflex, a possible mechanism of the hypotensive action of clonidine. Naunyn Schmiedebergs Arch Pharmacol 278:231-246, 1973
54. Starke K: Regulation of noradrenaline release by presynaptic receptor system. Rev Physiol Biochem Pharmacol 77:1-124, 1977
55. Goodman Gilman A, Goodman LS, Gilman A: The Pharmacological Basis of Therapeutics. New York, Macmillan, 1980
56. Stanszek WK, Kellerman D, Brodgen RN, Romankiewicz JA: Prazosin update. A review of its pharmacological and therapeutic use in hypertension and congestive heart failure. Drugs 25:339-384, 1983
57. Davey MJ: Relevant features of the pharmacology of prazosin: J Cardiovasc Pharmacol 2(suppl 3):s287-s302, 1980
58. Raasch W, Regunathan S, Li G, Reis DJ: Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci 56:2319-2330, 1995
59. Parini A, Moudanos CG, Pizzinat N, Lanier SM: The elusive family of imidazoline bindings sites. TIPS 17:13-17, 1996
60. Glavin GB, Hall AM: Brain-gut relationships: Gastricmucosal defense is also important. In Cell Injury and Protection in the Gastrointestinal Tract: From Basic Sciences to Clinical Perspectives. Gy Mózsik, Á Pár, G Csomós, M Kitajima, M Kondo, CJ Pfeiffer, KD Rainsford, P Sikiric, S Szabo (eds). Budapest, Akadémiai Kiadó. 1992, pp 107-115
61. Henke PG, Ray A: Stress ulcer modulation by limbic system structures. In Cell Injury and Protection in the Gastrointestinal Tract: From Basic Sciences to Clinical Perspectives. Gy Mózsik, Á Pár, G Csomós, M Kitajima, M Kondo, CJ Pfeiffer, KD Rainsford, P Sikiric, S Szabo (eds). Budapest, Akadémiai Kiadó, 1992, pp 117-125
62. Sikiric P, Rotkvic I, Mise S, Petek M, Rucman R, Seiwerth S, Zjacic Rotkvic V, Duvnjak M, Jagic V, Suchanek E, Grabarevic Z, Anic T, Brkic T, Djermanovic Z, Dodig M, Marovic A, Hernandez DE: Dopamine agonists prevent duodenal ulcer relapse: A comparative study with famotidine and cimetidine. Dig Dis Sci 36:905-910, 1991
63. Brodie DA, Valitski LS: Production of gastric hemorrhage in rats by multiple stresses. Proc Soc Exp Biol Med 113:998-1001, 1963